Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping

GlobeNewswireOct 8 22:00

GenomOncology Partners With Precipio to Advance Myeloid Testing and Reporting

PR NewswireSep 10 20:30

Express News | Precipio Inc - Options Granted in 2023 and in 2024 Will Remain Unaltered

BreakingsSep 7 04:03

Express News | Precipio- Repricing Stock Options Granted Prior to Year-End 2022, Representing About 58% of Total Outstanding Options

BreakingsSep 7 04:02

Precipio Announces Employee Stock Option Plan Repricing

GlobeNewswireSep 7 04:00

Zacks Initiates Coverage of Precipio With Outperform Recommendation

BarchartSep 5 22:56